Incidence and Outcomes of Contrast-Induced AKI Following Computed Tomography

Computed Tomography Steven D. Weisbord,* Maria K. Mor,* Abby L. Resnick,* Kathryn C. Hartwig,* Paul M. Palevsky, and Michael J. Fine* *Center for Health Equity Research and Promotion and Renal Section, Medical Specialty Service Line, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania; Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; and Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

[1]  R. Solomon.  Contrast-induced acute kidney injury: is there a risk after intravenous contrast? , 2008 .

[2]  M. Fine,et al.  Prevention, incidence, and outcomes of contrast-induced acute kidney injury. , 2008, Archives of internal medicine.

[3]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[4]  C. Becker,et al.  Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. , 2006, Reviews in cardiovascular medicine.

[5]  Gilles Soulez,et al.  Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Computed Tomography: A Double-Blind Comparison of Iodixanol and Iopamidol , 2006, Investigative radiology.

[6]  F. Veglia,et al.  N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. , 2006, The New England journal of medicine.

[7]  M. Fine,et al.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. , 2006, Journal of the American Society of Nephrology : JASN.

[8]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[9]  Richard Solomon,et al.  Contrast Media and Nephropathy: Findings From Systematic Analysis and Food and Drug Administration Reports of Adverse Effects , 2006, Investigative radiology.

[10]  R. Solomon.  The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. , 2005, Kidney international.

[11]  S. Weisbord,et al.  Radiocontrast-Induced Acute Renal Failure , 2005, Journal of intensive care medicine.

[12]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[13]  A. Martínez-Vea,et al.  Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydratation. , 2004, Clinical nephrology.

[14]  D. Hilleman,et al.  Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. , 2003, American heart journal.

[15]  P. Aspelin,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[16]  A. Agrawal,et al.  A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.

[17]  S. Fishbane,et al.  A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. , 2002, Kidney international.

[18]  K. Shyu,et al.  Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. , 2002, Journal of the American College of Cardiology.

[19]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[20]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[21]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[22]  N. Chalmers,et al.  Comparison of iodixanol and iohexol in renal impairment. , 1999, The British journal of radiology.

[23]  Allen J. Taylor,et al.  Clinical InvestigationsCardiologyPREPARED: PREParation for Angiography in REnal Dysfunction: A Randomized Trial of Inpatient vs Outpatient Hydration Protocols for Cardiac Catheterization in Mild-to-Moderate Renal Dysfunction , 1998 .

[24]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[25]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[26]  P. Parfrey,et al.  Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. , 1992, Kidney international.

[27]  Y. Wang,et al.  Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. , 1990, The American journal of medicine.

[28]  L. Fisher,et al.  Risks for renal dysfunction with cardiac angiography. , 1986, Annals of internal medicine.

[29]  W. O’Neill,et al.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. , 1999, Journal of the American College of Cardiology.

[30]  B. Barrett.  Contrast nephrotoxicity. , 1994, Journal of the American Society of Nephrology : JASN.